Green Bioactives (GBL) has completed a £2.6 million ($3.1 million) seed financing round, which it says will accelerate its production, management, capabilities, and research team. According to GBL – a firm that focuses on the sustainable manufacture of natural products from plant cell cultures – it will use the funding round led by Eos Advisory LLP and others to follow sector-specific partnerships, increase product sales, up its marketing activity, and establish intellectual property (IP) across the company’s core biomanufacturing process…